Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Effect of More Expedited Carotid Intervention on Recurrent Events

This study shows the benefit of reducing waiting time between acute events and intervention in patients with severe symptomatic carotid stenosis. Its outcomes support the efforts to reduce patient management. Moreover, it could be used as an indicator of clinical practice quality.

Claves para mejorar la productividad en la sala de cateterismoThe risk of recurrent events after an ischemic event is significantly higher in the early phase because of extracranial carotid stenosis, which is why guidelines recommend a short delay (to perform either endarterectomy or stenting).

 

Data on all endarterectomy and all stenting on symptomatic stenosis patients were obtained from the Swedish Vascular Registry between 2008 and 2015. Data included all secondary events occurring after the presenting event up to 30 days follow up with inclusion of all pre- and post-intervention recurrences.


Read also: Safety of Early Carotid Artery Stenting in Symptomatic Patients.


Primary end point was recurrent cerebral ischemic event occurring after the presenting event up to 30 days of post-operative follow up.

 

The study looked at 6814 patients and showed a reduction of recurrent ischemic events (31% in 2008/09 to 21% in 2014/15; p=0.01) and, in parallel, mean time from index event to intervention was reduced from 13 to 7 days.


Read also: Is Stage 1 Hypertension as Defined in ACC/AHA Guidelines Associated with Any Events?


The proportion of recurrent events during waiting time was reduced from 25% to 18% (p<0.01) while periprocedural events (death and stroke) were 3.6%, and improved slightly during the studied period.

Conclusion

A substantial reduction of recurrent events is observed when mean waiting time between index procedure and intervention (endarterectomy or stenting) is reduced. This reduction of events during waiting time is in no way counterbalanced by an increase in periprocedural events.

Original title: Effect of More Expedited Carotid Intervention on Recurrent Ischaemic Event Rate: A National Audit.

Reference: Björn Kragsterman et al. Eur J Vasc Endovasc Surg (2018), article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

C-TRACT: Endovascular therapy in post-thrombotic syndrome due to iliac obstruction

Post-thrombotic syndrome (PTS) is one of the most limiting sequelae following proximal deep vein thrombosis (DVT). It clinically manifests as chronic pain, edema, skin...

Coil embolization of segmental arteries as a spinal cord protection strategy prior to complex endovascular repair of thoracoabdominal aorta

Spinal cord ischemia remains one of the most devastating complications in the repair of thoracoabdominal aneurysms, with incidences of up to 20–30% in extensive...

Mechanical thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism: systematic review and meta-analysis

Intermediate-risk pulmonary embolism (PE) has anticoagulation as the standard treatment, while reperfusion strategies remain a matter of debate. In this context, mechanical thrombectomy has...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...